ValitaCell's Quantum 'At-line' innovation was shortlisted by the Irish Times expert panel for the Innovation of the Year Award for 2020. ValitaCell’s Quantum ‘At-line’ technology enables biopharmaceutical companies to analyse the quality and quantity of their cell samples in real-time at the bioreactor, dramatically saving time and money.
The manufacturing process of innovative medicines for a clinical trial or market launch can cost millions and these medicines are extremely challenging to manufacture. Quantum ‘At-line’ technology is directly integrated at the bioreactor, enabling rapid and accurate analysis.
The lead scientists and inventors of the Quantum technology are: Dr. Hannah Byrne, Head of Biological Science and Dr. Ben Thompson, Chief Technology Officer.